[144] TAT Technologies Ltd SEC Filing

Rhea-AI Filing Summary

TAT Technologies Ltd (TATT) filed a Form 144 notifying the proposed sale of 9,375 ordinary shares through Oppenheimer & Co. on 08/29/2025 on NASDAQ with an aggregate market value of $353,718.75. The shares represent part of an employee stock option grant acquired from the issuer on 01/09/2023 and were to be paid in cash upon exercise. The filing shows 10,940,358 shares outstanding, and the seller reports no sales in the prior three months. By signing, the seller attests not to possess undisclosed material adverse information about the issuer.

Positive

• Transparent disclosure of broker, acquisition date, and payment method meets Rule 144 requirements
• Seller attests to absence of undisclosed material adverse information, reducing information asymmetry
• No sales in the prior three months, suggesting this is an isolated liquidity event

Negative

• Insider sale of company shares could be perceived negatively by some investors despite being small
• Limited detail on the identity of the selling person and motives beyond exercise and sale

Insights

Securities Analyst

TL;DR: Insiders plan a standard, non-aggregated sale of vested option shares via broker; not an unusual volume relative to outstanding shares.

The notice documents a routine Rule 144 sale of 9,375 shares acquired under an employee stock option plan. The transaction is executed through a broker and paid in cash upon exercise, indicating a straightforward liquidity event rather than a private transfer or complex consideration. The shares equal roughly 0.086% of the reported outstanding stock, a non-material percentage for most investors. No prior sales in the past three months are reported, and the filer certifies absence of undisclosed material information.

Corporate Governance Expert

TL;DR: Governance disclosure is complete for a Rule 144 notice; the attestation reduces information-risk concerns.

The Form 144 includes required acquisition details, broker identification, and an attestation that the seller lacks undisclosed material information. The origin of the shares from an employee stock option plan is stated, which is typical for insider liquidity events. The filing does not indicate any clustered or aggregated disposals that might suggest coordinated insider selling pressure. Documentation appears compliant with Rule 144 disclosure norms.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	9375	353718.75	10940358	08/29/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	01/09/2023	Employee Stock Option Plan	From the Issuer			9375	08/29/2025	Cash - Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does TATT propose to sell under Form 144?

The filing notifies a proposed sale of 9,375 ordinary shares of TAT Technologies Ltd.

When and where will the TATT shares be sold?

The sale is scheduled for 08/29/2025 on NASDAQ through Oppenheimer & Co.

How were the shares acquired for the TATT Form 144 filing?

The shares were acquired on 01/09/2023 under an employee stock option plan from the issuer.

What is the aggregate value and outstanding share count reported?

Aggregate market value is reported as $353,718.75 and the filing lists 10,940,358 shares outstanding.

Were there any sales by the same person in the prior three months?

The filing reports Nothing to Report for securities sold during the past three months.